Medication-based Refill Adherence Among Pregnant Women Living With HIV in Nigeria.

Journal: Clinical therapeutics

Volume: 42

Issue: 11

Year of Publication: 2021

Affiliated Institutions:  School of Nursing and Midwifery, Centre for Quality and Patient Safety Research, Institute for Health Transformation, Faculty of Health, Deakin University, Victoria, Australia. Electronic address: oomonaiy@deakin.edu.au. School of Nursing and Midwifery, Centre for Quality and Patient Safety Research, Institute for Health Transformation, Faculty of Health, Deakin University, Victoria, Australia. Department of Nursing, The University of Melbourne, Melbourne, Victoria, Australia; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Victoria, Australia. Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Victoria, Australia.

Abstract summary 

A major global public health challenge is the continuance of new pediatric HIV infections primarily because of mother to child transmission of HIV occurring mainly in sub-Saharan African countries. The purpose of this study was to examine antiretroviral therapy (ART) refill adherence and its determinants among pregnant women living with HIV in Nigeria.A retrospective review of pharmacy refill records was undertaken to examine adherence data on 275 pregnant women undergoing ART in 4 high-volume HIV treatment sites in Nigeria. A pharmacy refill adherence measure was used to assess medication refill behavior of pregnant women living with HIV who had received an ART refill during a period of 3 months. Medication-based ART refill adherence was categorized as % adherence (100% adherence) or % nonadherence (<100% adherence) to the ART refill scheduled dates. Refill appointments were scheduled on a 28-day cycle. Multivariable logistic regression analysis was performed.Of the 275 women, 59.3% (95% CI, 53.1%-65.5%) were adherent to their ART refill schedule. Women who initiated ART during the third trimester of their current pregnancy had the lowest adherence rate of 30.8% (95% CI, 7.7%-53.8%) compared with women who commenced ART before conception or during the first or second trimester. The availability of a treatment support person was significantly associated with ART refill adherence. The odds of medication-based refill adherence were 2.9 times higher for participants who had a treatment support person (odds ratio = 2.9; 95% CI, 1.6-5.2; p = 0.001).Results indicate that having a treatment support person could contribute to improving ART adherence in pregnant women living in Nigeria.

Authors & Co-authors:  Omonaiye Olumuyiwa O Nicholson Pat P Kusljic Snezana S Mohebbi Mohammadreza M Manias Elizabeth E

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  5
Identifiers
Doi : 10.1016/j.clinthera.2020.08.014
SSN : 1879-114X
Study Population
Women
Mesh Terms
Adolescent
Other Terms
HIV;Nigeria;mother to child transmission;pediatric;sub-Saharan Africa
Study Design
Cross Sectional Study
Study Approach
Country of Study
Niger
Publication Country
United States